Susquehanna International Group, LLP Amphastar Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$36.99 - $50.09 $59,184 - $80,144	-1,600 Reduced 7.84%	18,800 $912,000
Q2 2024 Aug 15, 2024	SELL	$38.65 - $43.48 $954,655 - $1.07 Million	-24,700 Reduced 54.77%	20,400 $816,000
Q1 2024 May 07, 2024	BUY	$42.85 - $63.45 $886,995 - $1.31 Million	20,700 Added 84.84%	45,100 $1.98 Million
Q4 2023 Feb 14, 2024	BUY	$44.49 - $62.93 $75,633 - $106,981	1,700 Added 7.49%	24,400 $1.51 Million
Q3 2023 Nov 14, 2023	SELL	$45.51 - $65.0 $268,509 - $383,500	-5,900 Reduced 20.63%	22,700 $1.04 Million
Q2 2023 Aug 11, 2023	BUY	$35.77 - $58.38 $600,936 - $980,784	16,800 Added 142.37%	28,600 $1.64 Million
Q1 2023 May 16, 2023	BUY	$27.99 - $37.92 $117,558 - $159,264	4,200 Added 55.26%	11,800 $442,000
Q4 2022 Feb 14, 2023	SELL	$27.93 - $31.27 $572,565 - $641,035	-20,500 Reduced 72.95%	7,600 $212,000
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $2.6 Million - $3.56 Million	-94,300 Reduced 77.04%	28,100 $790,000

286

35.1M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.19B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.